Cost of mental and behavioural disorders in Kenya
Open Access
- 1 January 2003
- journal article
- Published by Springer Nature in Annals of General Hospital Psychiatry
- Vol. 2 (1) , 7
- https://doi.org/10.1186/1475-2832-2-7
Abstract
The health and economic impact of mental and behavioural disorders (MBD) is wide-ranging, long-lasting and large. Unfortunately, unlike in developed countries where studies on the economic burden of MBD exist, there is a dearth of such studies in the African Region of the World Health Organization. Yet, a great need for such information exists for use in sensitizing policy-makers in governments and civil society about the magnitude and complexity of the economic burden of MBD. The purpose of this study was to answer the following question: From the societal perspective (specifically the families and the Ministry of Health), what is the total cost of MBD patients admitted to various public hospitals in Kenya? Drawing information from various secondary sources, this study used standard cost-of-illness methods to estimate: (a) the direct costs, i.e. those borne by the health care system and the family in directly addressing the problem of MBD; and (b) the indirect costs, i.e. loss of productivity caused by MBD, which is borne by the individual, the family or the employer. The study was based on Kenyan public hospitals, either dedicated to care of MBD patients or with a MBD ward. The study revealed that: (i) in the financial year 1998/99, the Kenyan economy lost approximately US$13,350,840 due to institutionalized MBD patients; (ii) the total economic cost of MBD per admission was US$2,351; (iii) the unit cost of operating and organizing psychiatric services per admission was US$1,848; (iv) the out-of-pocket expenses borne by patients and their families per admission was US$51; and (v) the productivity loss per admission was US$453. There is an urgent need for research in all African countries to determine: national-level epidemiological burden of MBD, measured in terms of the prevalence, incidence, mortality, and, probably, the disability-adjusted life-years lost; and the economic burden of MBD, broken down by different productive and social sectors and occupations of patients and relatives.Keywords
This publication has 8 references indexed in Scilit:
- Proposed declassification of disease categories related to sexual orientation in theInternational Statistical Classification of Diseases and Related Health Problems(ICD-11)Bulletin of the World Health Organization, 2014
- Willingness-to-pay for schistosomiasis-related health outcomes in Kenya.2007
- Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness studyBMJ, 1998
- The cost of treating paediatric malaria admissions and the potential impact of insecticide‐treated mosquito nets on hospital expenditureTropical Medicine & International Health, 1998
- A cost analysis of Kilifi and Malindi public hospitals in Kenya.1998
- Cost Benefit of Sumatriptan to an EmployerJournal of Occupational and Environmental Medicine, 1997
- Healthcare Resource and Lost Labour Costs of Migraine Headache in the USPharmacoEconomics, 1992
- Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988.1991